NCT04460443Unknown2 期
Sofosbuvir Based Regimens in Treatment of COVID 19 Patients
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Number of patients with response to treatment
研究概览
简要总结
Sofosbuvir containing treatment in treatment of COVID 19 Egyptian patients
详细描述
Sofosbuvir containing treatment of COVID 19 Egyptian patients: a randomized-controlled trial
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Covid positive patients.
排除标准
- •Contraindication to sofosbuvir or ribavirin.
研究组 & 干预措施
Sofosbuvir and ledipsavir
Experimental
Sofosbuvir and ledipsavir plus standard of care treatment.
干预措施: Sofosbuvir ledipsavir (Drug)
Sofosbuvir and Daklatasuvir
Experimental
Sofosbuvir and Daklatasuvir plus standard of card treatment..
干预措施: sofosbuvir (Drug)
Sofosbuvir and Daklatasuvir
Experimental
Sofosbuvir and Daklatasuvir plus standard of card treatment..
干预措施: Daclatasvir (Drug)
结局指标
主要结局
Number of patients with response to treatment
时间窗: 1 month
The total number of patients with response to treatment
次要结局
未报告次要终点
研究者
Sherief Abd-Elsalam
Ass. Prof. Tropical Medicine
Tanta University
研究点 (1)
Loading locations...
相似试验
Unknown
2 期
Sofosbuvir Containing Regimens in Treatment of COVID 19 PatientsCovid19NCT04497649Tanta University100
已完成
3 期
Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard TreatmentCovid19NCT04530422Almaza Military Fever Hospital250
Unknown
2 期
Safety and Efficacy of Gratisovir (Sofosbuvir)- Ribavirin Therapy in Pediatric PatientsPharmacological ActionNCT02985281National Liver Institute, Egypt41
Unknown
不适用
Ivermectin In Treatment of COVID 19 PatientsCovid19NCT04425707Ministry of Health and Population, Egypt100
已完成
4 期
Evaluation of Sofosbuvir and Daclatasvir Combo in COIVD-19 Patients in EgyptCovid19NCT04773756Alexandria University54